Opus Genetics
IRD
27 hedge funds and large institutions have $2.58M invested in Opus Genetics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4% more funds holding
Funds holding: 26 → 27 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
1% less capital invested
Capital invested by funds: $2.62M → $2.58M (-$32.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$155K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$30.6K |
| 3 |
Jane Street
New York
|
+$24.3K |
| 4 |
BlackRock
New York
|
+$21.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$9.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$26K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$8.79K |
| 3 |
Bank of New York Mellon
New York
|
-$8.17K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$7.12K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Group One Trading
Chicago,
Illinois
| – | -$7.12K | -81 | Closed |
|
|
27
Bank of America
Charlotte,
North Carolina
| – | -$1.32K | -15 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$1K | -8 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$176 | +2 | +22% |
|
|
CF
30
Centaurus Financial
Anaheim,
California
| – | +$352 | +4 | New |
|
|
SMFS
31
Squar Milner Financial Services
Irvine,
California
| – | +$352 | +4 | New |
|
IRD Hedge Fund Activity: Q2 2018 in Review
27 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2018, worth a combined $2.58M — down 1.3% from $2.62M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IRD positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $155K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $26K sold.
- 27 institutional investors held Opus Genetics (IRD) as of Q2 2018, up from 26 in Q1 2018.
- Funds reported $2.58M of Opus Genetics stock for Q2 2018, down 1.3% quarter-over-quarter.
- 6 funds opened new Opus Genetics positions in Q2 2018 and 5 closed out, a net change of +1 holder.
- The largest Opus Genetics buyer in Q2 2018 was Virtu Financial, an estimated $155K added.
- The largest Opus Genetics seller in Q2 2018 was Renaissance Technologies, an estimated $26K sold.
Based on aggregated 13F filings for Q2 2018.